Higher efficacy of oral etoposide for mobilization of peripheral blood stem cells in patients with multiple myeloma
Abstract. This study compares the efficacy, toxicity, hematopoietic recovery, and cost of stem-cell mobilization using intermediate-dose cyclophosphamide (IDCy) plus granulocyte colony-stimulating factor (G-CSF) compared with etoposide (VP-16) plus pegylated granulocyte colony-stimulating factor (PE...
Main Authors: | Wanting Qiang, Hua Jiang, Pei Guo, Jing Lu, Jin Liu, Lu Li, Haiyan He, Xiaoxia Hu, Weijun Fu, Juan Du |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Health
2022-04-01
|
Series: | Blood Science |
Online Access: | http://journals.lww.com/10.1097/BS9.0000000000000104 |
Similar Items
-
Prospective Comparative Study of Etoposide plus G-CSF versus G-CSF Alone, Followed by Risk-Adapted Plerixafor for Peripheral Blood Stem Cell Mobilization in Patients with Newly Diagnosed Multiple Myeloma: CAtholic REsearch Network for Multiple Myeloma Study (CAREMM-2001)
by: Sung-Soo Park, et al.
Published: (2023-09-01) -
PB2453: FACTORS INFLUENCING AUTOLOGOUS PERIPHERAL BLOOD STEM CELL MOBILIZATION IN LYMPHOMA AND MULTIPLE MYELOMA
by: Ran Longrong, et al.
Published: (2023-08-01) -
PB2138: ORAL REGIMEN SELINEXOR, POMALIDOMIDE, AND DEXAMETHASONE IN RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA (RRMM): SAFETY ASSESSMENT AND OPTIMIZATION
by: Juan Du, et al.
Published: (2023-08-01) -
Outcomes of poor peripheral blood stem cell mobilizers with multiple myeloma at the first mobilization: A multicenter retrospective study in Japan
by: Yurie Miyamoto‐Nagai, et al.
Published: (2022-08-01) -
A comparison of peripheral blood stem cell collection outcomes for multiple myeloma; mobilization matters in the era of IMiD induction
by: Thea Chandler, et al.
Published: (2023-08-01)